Business
Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
HAMPTON, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that management will participate in a fireside chat
About this update from Celldex Therapeutics, Inc.
HAMPTON, N.J. , Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics , Inc. (NASDAQ:CLDX) announced that management will participate in a fireside chat today, September 9th, 2025 , at the Morgan Stanley 23rd Annual Global Healthcare Conference at 3:20 pm ET . A live webcast of the presentation will be available on the " Events & Presentations ” page of the " Investors " section of the Celldex website . A replay will be available for 90 days following the event. About Celldex Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. Visit www.celldex.com . Company Contact Sarah Cavanaugh Senior Vice President, Corporate Affairs & Administration(508) 864-8337 [email protected] Patrick Till Meru Advisors (484) 788-8560 [email protected] Source: Celldex Therapeutics, Inc.
View stock analysis, news, and events for Celldex Therapeutics, Inc.